|
|
SOIE 2008 CONGRESS – Scientific Program
“Problems and Controversies in Uveitis and Ocular Inflammation
(basic, intermediate and advanced problematics)” |
Developments in dry eye
Moderators: Murat Irkec,Turkey and Anthony J. Bron, United Kingdom
Sponsored by Abdi Ibrahim Turkey |
| 13.30-13:40 | Introduction
Murat Irkec, Turkey |
| 13:40-14:00 | Pathogenesis of Dry Eye
Banu Bozkurt, Turkey |
| 14:00-14:20 | Diagnosis of Dry Eye
Anthony Bron, United Kingdom |
| 14:20-14:45 | Treatment of Dry Eye
Murat Irkec, Turkey |
| 14.45–14.55 | Discussion |
What is new in ocular allergy
Moderators: Yonca Akova, Turkey and Talin Barisani-Asenbauer, Austria
Sponsored by Alcon Turkey |
| 15.00-15.20 | Seasonal and perennial allergic conjunctivitis
Pia Allegri, Italy |
| 15.20-15.40 | Vernal/atopic keratoconjunctivitis
Yonca A. Akova, Turkey |
| 15.40-16.00 | Differential diagnosis in allergic disease
Ozlem Evren, Turkey |
| 16.00-16.25 | New therapeutic modalities in allergic eye disease
Talin Barisani-Asenbauer, Austria |
| 16.25-16.40 | Discussion |
Rapid-fire presentations
(Conjunctiva, cornea, sclera, orbit)
Moderators:Ozlem Evren, Sumru Onal, Turkey |
| 16:45-16:48 | A new experimental ocular allergy model with beta-lactoglobulin
Ayca Sari,Erdem Dinc, Banu Yilmaz, Ufuk Adiguzel and Bahar Tasdelen, Turkey |
| 16:48-16:51 | Investigation of human papillomavirus and epstein-barr virus DNA’s in pterygium tissue
Sinan Emre,Baris Otlu, Peykan Turkcuoglu, Selim Doganay and Riza Durmaz, Turkey |
| 16:51-16:54 | Demographic and clinical features, systemic associations and prognosis in scleritis patients
Leyla Erkanli,Ilknur Tugal-Tutkun, Yonca Akova and Esra Guney-Tefekli, Turkey |
| 16:54-16:57 | A case of sclero-keratitis treated with rituximab
Barbara Iaccheri and Tito Fiore, Italy |
| 16:57-17:00 | Idiopathic Orbital Inflammatory Disease
Seyda Ugurlu,Elif D. Biler, Deniz Egrilmez and Ilkay C. Mermut, Turkey |
| 17:00-17:03 | Complete ophthalmoplegia in a patient with ophthalmic herpes zoster
Nursen Ariturk, Turkey |
| 17:03-17:06 | Ocular findings in primary varicella infection
Gulten Sungur,Dicle Hazirolan, Serkan Duran, Banu Satana and Sunay Duman, Turkey |
| 17:06-17:20 | Discussion |
| 17:30-18:00 | Opening Ceremony |
| 18:00-18:45 | Opening Lecture – History of Cappadocia
Engin Akyurek, Turkey |
| 19:00-20:00 | Welcome Reception |
| Friday, 13 June 2008 |
| 08:00-18:00 | Registration |
Basics
Moderators:Amod Gupta, India and Haluk Kazokoglu, Turkey
|
| 08:15-08:30 | Update on mechanisms of intraocular inflammation with focus on clinical implications (the role of TNF-alpha in inflammation)
Gerhild Wildner, Germany |
| 08:30-08:45 | Uveitis classification with focus on intermediate uveitis : misconcepts and rectifications
Moncef Khairallah, Tunisia |
| 08:45–09:00 | Epidemiologic data on uveitis in Turkey with emphasis on Turkish situation in Fuchs and HLA-B27 uveitis
Haluk Kazokoglu, Turkey |
| 09:00-09:20 | Rational approach to systemic investigations
Philip Ian Murray, United Kingdom |
| 09:20-09:40 | Rational approach to imaging in uveitis
Carl P. Herbort, Switzerland |
| 09:40-10:10 | Controversy No 1: Fuchs’uveitis
1. Fuchs’ uveitis should be classified as an anterior uveitis (8’)
Philippe Kestelyn, Belgium
2. Fuchs should be clasified as an intermediate uveitis (8’)
A. Abu El Asrar, Saudi Arabia
3. Synthesis (8’)
Carl P. Herbort, Switzerland
4. Input from the audience (6’)
|
| 10:10-10:30 | Coffee break |
Specific entities I
Moderators:Moncef Khairallah, Tunisia and Figen Batioglu, Turkey |
| 10:30-10:40 | HLA-B27 uveitis
Stephan Thurau, Germany |
| 10:40-11:05 | Controversy No 2 : are TNF-alpha inhibitors warranted in HLA-B27 related uveitis
1. TNF-alpha blockers are not justified (5’)
Philip Ian Murray, United Kingdom
2. Rheumatology point of view (10’)
Ahmet Gul, Turkey
3. Synthesis (5’)
Moncef Khairallah, Tunisia
4. Input from the audience (5’)
|
| 11:05-11:20 | Ocular toxoplasmosis- typical vs atypical presentations / when and how to treat
Carlos Pavésio, United Kingdom |
| 11:20-11:40 | Choroidal inflammation (choriocapillaropathy vs stromal based on type of inflammatory process) and Birdshot retinochoroidopathy
Carl P. Herbort, Switzerland |
| 11:40-11:50 | VKH : quick overview of clinical signs and treatment
Manabu Mochizuki, Japan
|
| 11:50-12:00 | Sympathetic ophthalmia: quick overview of clinical signs and treatment
Ahmed Abu El Asrar, Saudi Arabia
|
| 12:00-12:40 | Nomenclature of ocular vasculitis (10’)
Manfred Zierhut, Germany
Controversy No3: Retinal vasculitis- is it just a sign or an entity?
1. Pro : it is an entity (10’)
Ahmed Abu El Asrar, Saudi Arabia
2. Con : it is just a sign (10’)
Pia Allegri, Italy
3. Synthesis (5’)
Manfred Zierhut, Germany
4. Input from the audience (5’) |
| 12:40-13:40 | Lunch |
| 14:00-18:00 | Excursion ( Ihlara Valley ) |
| Saturday, 14 June 2008 |
| 08:00-18:00 | Registration |
How should we monitor intraocular inflammation
Moderators : Carl Herbort, Switzerland and Yilmaz Ozyazgan, Turkey
|
| 08:30-08:55 | We have precise tools to monitor intraocular inflammation : why not use them? Laser flare photometry
Basic principles & Lausanne experience(12’)
Carl P. Herbort, Switzerland
Moorfields experience (8’)
Carlos Pavésio, United Kingdom
Experience in Behçet disease (5’)
Ilknur Tugal-Tutkun, Turkey |
| 08:55-09:10 | Angiographic scoring system: why do we need semi-quantitative measurements of angiographic data?
With examples
Ilknur Tugal-Tutkun, Turkey and Carl Herbort, Switzerland |
| 09:10-09:25 | Ocular sarcoidosis clinical presentation, example of a successful nomenclature standardization and therapy
Manabu Mochizuki, Japan |
| 09:25-09:45 | Coffee break
|
Specific entities II (infectious)
Moderators:Philippe Kestelyn, Belgium and Yonca Akova, Turkey |
| 09:45-10:00 | Ocular tuberculosis
Amod Gupta, India |
| 10:00-10:15 | Are all serpiginous related to tuberculosis?
Vishali Gupta, India |
| 10:15-10:25 | Gamma IFN assays in the diagnosis of tuberculosis
Luca Cimino, Italy |
| 10:25-10:35 | Cat scratch disease
Andre Curi, Brazil |
| 10:35-10:45 | Ocular syphilis
Philippe Kestelyn, Belgium |
| 10:45–11:00 | Viral retinopathies
Carl P. Herbort, Switzerland |
| 11:00-11:15 | West Nile virus and Ricketsial uveitis
Moncef Khairallah, Tunisia |
| 11:15-11:25 | Opportunistic infections in transplant patients
Yonca Akova, Turkey |
Pediatric Uveitis & Masquerades
Moderators:Stephan Thurau, Germany and Sibel Kadayifcilar, Turkey |
| 11:30-11:45 | Pars planitis in childhood
Barbara Biziorek, Poland |
| 11:45-12:00 | JIA associated uveitis
Tülin Berk, Turkey |
| 12:00-12:15 | Primary intraocular lymphoma
Nathalie Cassoux,France |
| 12:15-13:30 | Lunch |
Behcet Disease
Moderators: Manabu Mochizuki, Japan and Ahmed A. El Asrar, Saudi Arabia |
| 13:30-14:05 | Controversy No4: Should we develop ocular diagnostic criteria?
1. Pro :Yes, we should (12’)1. Pro :Yes, we should (12’)
Ilknur Tugal-Tutkun, Turkey
2. Con: No, we do not need (12’)
Nikos Markomichelakis, Greece
3. Synthesis (6’)
Manabu Mochizuki, Japan
4. Input from the audience (5’)
|
| 14:05-14:50 | What is the best treatment of Behçet uveitis?
How do we monitor the disease activity in the management of Behçet’s patients? (10’)
Ahmet Gul, Turkey
What should be the first line of systemic treatment? Evidence-based therapy or .. ? (10’)
Yilmaz Ozyazgan, Turkey
Why do we prefer interferon alpha? (10’)
Manfred Zierhut, Germany
Why do we prefer anti-TNF alpha? (10’)
Nikos Markomichelakis, Greece
Discussion (5’)
|
Rapid fire presentations
Chairpersons :Manfred Zierhut, Germany and Luca Cimino, Italy |
| 14:50-14:53 | Antigen-specific reinduction of experimental autoimmune uveitis in Lewis rats
Maria Diedrichs-Moehring,Christiane Hoffmann and Gerhild Wildner, Germany |
| 14:53-14:56 | Epidemiology of uveitis in a tertiary referral hospital in Turkey
Pinar Ozdal,Alper Yazici, Sevim Kavuncu, Ibrahim Taskintuna and Gultekin Koklu, Turkey |
| 14:56-14:59 | Clinical characteristics of uveitis in the elderly
Kurtulus Serdar,Pinar Ozdal, Alper Yazici, Sevim Kavuncu, Ibrahim Taskintuna and Gultekin Koklu, Turkey |
| 14:59-15:02 | Non-infectious causes of anterior uveitis in children
Aylin Yaman,Ziya Ayhan, Erbil Ünsal and A Tulin Berk, Turkey |
| 15:02-15:05 | Trabeculectomy versus Ahmed valve in children with juvenile idiopathic arthritis-associated uveitis
Karen M. Sijssens,Aniki Rothova, Jan S. Stilma and Joke H. de Boer, The Netherlands
|
| 15:05-15:08 | Pars Planitis: Ocular manifestations, complications and visual outcome
Nilufer Berker,Pinar Cakar Ozdal, Naciye Kabatas, Emel Soykan, Gultekin Koklu and Seyhan Sonar Özkan, Turkey
|
| 15:08-15:11 | Demographic and clinical features of Turkish patients with Fuchs’ Uveitis Syndrome
Esra Guney-Tefekli, Isik Corum, Fulya Kamaci and Ilknur Tugal-Tutkun, Turkey
|
| 15:11-15:14 | Rubella virus-associated uveitis: clinical manifestations and visual prognosis
Lenneke de Visser,Arthur Braakenburg, Aniki Rothova and Joke H. de Boer, The Netherlands
|
| 15:14-15:17 | Ocular manifestations in HTLV-1 patients and its correlation with proviral load
André Luiz Land Curi,Eliezer Benchimol, Marcus Tulius T Silva, Ana Claudia Leite, Marco Antonio Lima, Abelardo Araujo and Maria Jose Andrada-Serpa, Brazil
|
| 15:17-15:20 | Ocular toxoplasmosis in southern Turkey
Kemal Yar,Merih Soylu,Simge Altan, Turkey
|
| 15:20-15:23 | Diagnosis, Treatment and Visual Outcomes in Patients With Retinal Vasculitis
Burcu Aynaci Kahraman,Yonca Aydin Akova and Imren Akkoyun, Turkey
|
| 15:23-15:26 | The predictability of fluorescein angiography findings in determining Behçet’s disease
Sirel Gur Gungor,Yonca Aydın Akova, Cem Kucukerdomez and Meric Colak, Turkey
|
| 15:26-15:29 | Long-term Safety and Efficacy of Interferon Alpha-2a in Treatment of Patients with Behcet Uveitis
Gungor Sobaci, Turkey
|
| 15:29-15:32 | Safety and efficacy of low dose interferon alfa-2a in the treatment of refractory and sight-threatening Behçet’s uveitis: a prospective study of 16 cases
Sumru Onal,Haluk Kazokoglu, Aylin Koc, Tayfun Bavbek, Haner Direskeneli and Sule Yavuz, Turkey
|
| 15:32-15:35 | Effect of inravitreal bevacizumab on retinal endothelial cells and vitreal inflammatory activity
Akkoyun I.,Yilmaz G, OTO S, Erkanli L, Haberal N., Babacan D., Tufan H, Akova Y. A., Turkey
|
| 15:35-15:50 | Discussion |
| 16:00-18:00 | Excursion (Goreme valley and sunset at Uchisar) |
| Sunday, 15 June 2008 |
Treatment of intraocular inflammation
Moderators: Philip Ian Murray, United Kingdom and Pia Allegri, Italy
|
| 08:30-08:45 | Intraocular injections and devices
Carlos Pavesio, United Kingdom |
| 08:45-09:00 | Immunosuppressants - What’s new?
Piergiorgio Neri, Italy |
| 09:00-09:15 | Update on interferons
Manfred Zierhut, Germany |
| 09:15-09:45 | Anti-TNF therapy
Update in rheumatology (15’)
Ahmet Gul, Turkey
Update in ophthalmology (15’)
Nikos Markomichelakis, Greece
|
| 09:45-10:00 | Future trends
Stephan Thurau, Germany |
| 10:00-10:10 | Discussion |
| 10:10-10:30 | Coffee break |
Management of complications of uveitis
Moderators:Carlos Pavesio, United Kingdom and Bora Eldem, Turkey |
| 10:30-10:45 | Uveitic glaucoma
Carl P. Herbort, Switzerland |
| 10:45-11:00 | Cataract surgery
Carlos Pavesio, United Kingdom |
| 11:00-11:15 | Vitreoretinal surgery & diagnostic collection of intraocular fluids
Vishali Gupta, India |
| 11:15-11:40 | Choroidal neovascularizations:
The role of inflammation in the pathogenesis of CNVM (10’)
Piergiorgio Neri, Italy
Current treatment options (15’)
Merih Soylu, Turkey |
Rapid-fire presentations & Case presentations
Moderators: Vishali Gupta, India and Merih Soylu, Turkey |
| 11:45-11:48 | Ophthalmic microendoscopy in eyes with various etiologies of uveitis
Emin Ozmert and Figen Batioglu, Turkey |
| 11:48-11:51 | Hypotony -a late complication of cataract extraction in uveitis and review of underlying mechanisms
Chui Ming Gemmy Cheung, Singapore |
| 11:51-11:54 | Intraoperative Intravitreal Triamcinolone Acetonide during Phacoemulsification in Uveitic Patients
Sirel Gur Gungor, Yonca Aydin Akova and Cem Kucukerdonmez, Turkey |
| 11:54-11:57 | Sympathetic ophthalmia following vitreoretinal surgery
Zeynep Ozbek SoylemezogluGul Arikan, Aylin Yaman, Hakan Oner, Meltem Soylev Bajin and Ali Osman Saatci, Turkey |
| 11:57-12:00 | An unusual case of unilateral retinal capillaritis
Figen Batioglu, Emin Ozmert and Nilüfer Yalcindag, Turkey
|
| 12:00-12:03 | Ophthalmoparesis, papilledema, premacular hemorrhage: a rare presentation of brucellosis
Ozlem Sahin, Turkey
|
| 12:03-12:06 | Night blindness and uveitis as presenting manifestations of Whipple's disease
Ranjeet Pandit, United Kingdom
|
| 12:06-12:09 | Recurrent Acute Posterior Multifocal Placoid Pigment Epitheliopathy
Burcu Aynacı Kahraman and Yonca Aydın Akova, Turkey
|
| 12:09-12:12 | Recurrent exudative retinal detachment in a patient with Vogt- Koyanagi- Harada disease
Emre Altinkurt, Esra Guney-Tefekli and Ilknur Tugal-Tutkun, Turkey
|
| 12:12-12:20 | Discussion |
| 12:20-12:30 | Closing ceremony |
SOIE 2008 Congress Secretariat - ODS Congress
Management
ODS Congress Management Sari Asma Sok. No: 8, 34464 Yenikoy -
Sariyer,
Istanbul - Turkey
Phone :
+90 212 299 99 80
Fax :
+90 212 299 99 77
|
